ArticleCells2020

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia.

Dipnarine Maharaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.